...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: a $6 sell order drops ZEN 96% !

The day-to-day share price swings of "ZHCLF" on the OTC exchange do not matter.

What matters is "a royalty or partnership deal"  for "ZHCLF" when we are not on a proper exchange that provides us with stock liquidity as we see fit. 

 

Koo

Share
New Message
Please login to post a reply